In autochthonous transgenic prostate cancer TRAMP mice, inhibition of GSK3β resulted in reduction of tumor number and size through the derepression of C/EBPα and inhibition of E2F expression16. The gene discussed is CEBPA; the disease is prostate carcinoma.